WUXI APPTEC
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for s... mall molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
WUXI APPTEC
Industry:
Biotechnology Health Care Medical Device Outsourcing Pharmaceutical
Founded:
2000-12-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.wuxiapptec.com
Total Employee:
10001+
Status:
Active
Contact:
651-675-2000
Email Addresses:
[email protected]
Total Funding:
1.59 B USD
Technology used in webpage:
SPF SSL By Default Google Analytics LetsEncrypt Google Universal Analytics Domain Not Resolving Global Site Tag Nginx Sitelinks Search Box Amazon
Similar Organizations
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-03-01 | Oxford Genetics | Oxford Genetics acquired by WuXi AppTec | N/A |
| 2019-05-05 | Pharmapace | Pharmapace acquired by WuXi AppTec | N/A |
| 2017-10-17 | ResearchPoint Global | ResearchPoint Global acquired by WuXi AppTec | N/A |
| 2017-01-19 | HD Biosciences | HD Biosciences acquired by WuXi AppTec | N/A |
| 2016-04-15 | Crelux | Crelux acquired by WuXi AppTec | N/A |
| 2015-01-09 | NextCODE Health | NextCODE Health acquired by WuXi AppTec | 65 M USD |
Investors List
Ping An Bank
Ping An Bank investment in Debt Financing - WuXi AppTec
Warburg Pincus
Warburg Pincus investment in Post-IPO Equity - WuXi AppTec
Eight Roads Ventures
Eight Roads Ventures investment in Series C - WuXi AppTec
Eight Roads Ventures
Eight Roads Ventures investment in Series B - WuXi AppTec
Eight Roads Ventures
Eight Roads Ventures investment in Series A - WuXi AppTec
NewSpring
NewSpring investment in Venture Round - WuXi AppTec
Commerce Health Capital
Commerce Health Capital investment in Venture Round - WuXi AppTec
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-20 | ShouTi | WuXi AppTec investment in Series B - ShouTi | 100 M USD |
| 2021-06-03 | Stemirna | WuXi AppTec investment in Venture Round - Stemirna | 1.2 B CNY |
| 2021-05-28 | MegaRobo | WuXi AppTec investment in Corporate Round - MegaRobo | 65 M USD |
| 2021-05-26 | Engine Biosciences | WuXi AppTec investment in Series A - Engine Biosciences | 43 M USD |
| 2021-05-10 | OakMega | WuXi AppTec investment in Series A - OakMega | N/A |
| 2021-02-22 | AnchorDx | WuXi AppTec investment in Series C - AnchorDx | 40 M USD |
| 2021-02-09 | Drug Farm | WuXi AppTec investment in Series A - Drug Farm | 56 M USD |
| 2020-11-17 | D3 Bio | WuXi AppTec investment in Series A - D3 Bio | 200 M USD |
| 2020-06-11 | JW Therapeutics | WuXi AppTec investment in Series B - JW Therapeutics | 100 M USD |
| 2020-05-26 | Insitro | WuXi AppTec investment in Series B - Insitro | 143 M USD |
Newest Events participated
Participated in BioProcess International West 2017
on 2017-02-27 as sponsor
Official Site Inspections
http://www.wuxiapptec.com Semrush global rank: 819.81 K Semrush visits lastest month: 47.12 K
- Host name: 48.211.129.204
- IP address: 48.211.129.204
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "WuXi AppTec"
Biomarkers Market Size And Share | Industry Report, 2030
The global biomarkers market size was estimated at USD 162,087.0 million in 2023 and is projected to reach USD 388,433.7 million by 2030, growing at a CAGR of 13.3% from 2024 to …See details»
Biomarkers Market Size to Surge USD 318.76 Bn by 2034
May 7, 2025 Biomarkers Market Size and Forecast 2025 to 2034 The global biomarkers market size was estimated at USD 82.30 billion in 2024 and is anticipated to reach around USD …See details»
Biomarkers Market Size & Growth, Forecast 2025-2033
Sep 1, 2025 Biomarkers Market Trends The biomarkers market is witnessing transformative trends as healthcare providers and pharmaceutical companies emphasize early disease …See details»
Biomarkers Market Size, Forecast, Share & Growth Drivers 2030
Jul 1, 2025 Biomarkers Market Analysis by Mordor Intelligence The biomarkers market stood at USD 57.27 billion in 2025 and is forecast to reach USD 97.42 billion by 2030, delivering an …See details»
Biomarkers Market Size Grows by 14.54% CAGR till 2034
Aug 14, 2025 The biomarkers market size is projected to expand from USD 94.32 billion in 2024 to USD 366.6 billion by 2034, with a CAGR of 14.54%.See details»
Biomarkers Market Growth, Drivers, and Opportunities
Advancements in omics technologies drive growth in the biomarkers market by enabling precise identification of disease biomarkers and drug targets. Genomic, epigenomic, transcriptomic, …See details»
Biomarkers Market Size, Share, Growth | Industry Report, 2032
Aug 25, 2025 Biomarkers Market size was valued at $ 77.56 billion in 2024 & is projected to grow to $ 193.97 billion by 2032, at a CAGR of 12.1% during the forecast period.See details»
Biomarkers Market Size ($142.5 Billion) 2030
The Biomarkers Market was valued at $68.3 billion in 2024 and is projected to reach $142.5 billion by 2030, growing at a CAGR of 12.6%.See details»
Biomarkers Market Size, Forecast Size, Share, Trends & Forecast
Biomarkers Market: Definition/ Overview Biomarkers are biological indicators that provide measurable evidence of a biological process, condition, or disease state. They can be …See details»
Biomarkers Market – Global Market Size, Share, and Trends …
Biomarkers Market Trends Enhanced Convenience Through Technological Advancements A significant and accelerating trend in the global biomarkers market is the rapid adoption of …See details»
Biomarkers Market | USD 321.45 Billion by 2034
The biomarkers market size was exhibited at USD 91.65 billion in 2024 and is projected to hit around USD 321.45 billion by 2034, growing at a CAGR of 13.37% during the forecast period …See details»
Biomarkers Market Size, Trends, Share & Analysis, 2025-2032
Mar 21, 2025 Biomarkers Market is estimated to be valued at USD 81.5 Bn in 2025 and is expected to expand at CAGR of 13.6%, reaching USD 198.98 Bn in 2032.See details»
Biomarkers Market Size, Share and Growth Horizons to 2031
Market Outlook The biomarkers market covers a broad range of measurable signals, such as genetic variances, protein levels, and biochemical alterations, which indicate biological …See details»
Biomarkers Market Size, Share, 2033
The global biomarkers market size is expected to be worth USD 163.34 Bn by 2033 and showcase 12.27% CAGR from 2024 to 2033. The U.S. led the market in 2025.See details»
Biomarkers Market Size, Share | Industry Forecast 2024-2033
The global biomarkers market size was valued at $46.4 billion in 2023, and is projected to reach $134.2 billion by 2033, growing at a CAGR of 11.2%.See details»
Biomarkers Market Share, Growth Analysis Report 2025-2034
Biomarkers Market Size The global biomarkers market size was estimated at USD 77.6 billion in 2024. The market is expected to grow from USD 85.9 billion in 2025 to USD 244.8 billion by …See details»
Voice/Vocal Biomarkers Market to Quadruple in Size by 2035: …
1 hour ago Key market opportunities in the voice/vocal biomarker sector include early disease detection and prevention, especially for neurological, mental health, and respiratory conditions. …See details»
How AI & Biomarkers Are Reshaping the Next Frontier in Drug …
Aug 25, 2025 Discover how AI, biomarkers, and global clinical strategies are redefining the future of drug development. Insights from Precision for Medicine’s Dr. Deborah Phippard on …See details»
Trabalhe Conosco - Zilor
Trabalhe Conosco Somos uma empresa brasileira que traz em seu DNA a constante busca por Eficiência, Inovação, Produtividade e Sustentabilidade. Com quatro unidades agroindustriais …See details»
Toxic element levels in ingredients and commercial pet foods
Oct 25, 2021 In a study conducted by da Costa 45, which evaluated commercial foods for dogs and cats available in the Brazilian market, Al concentrations also determined by ICP-OES …See details»